Ioanna Drami

Ms. Ioanna Drami

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2022 in International Journal of Surgery
Verified
Journal Article
Closed access
LGLaura E. Gould
Laura E. Gould
EPEdward T. Pring
Edward T. Pring
IDIoanna Drami
Ioanna Drami
MMMorgan Moorghen
Morgan Moorghen
MNMani Naghibi
Mani Naghibi
CRCampbell Sd. Roxburgh
Campbell Sd. Roxburgh
Despite multimodal therapy 5-15% of patients who undergo resection for advanced rectal cancer (LARC) will develop local recurrence. Management of locally recurrent rectal cancer (LRRC) presents a significant therapeutic challenge and even with modern exenterative surgery, 5-year survival rates are poor at 25-50%. High rates of local and systemic recurrence in this cohort are reflective of the likely biological aggressiveness of these tumour types. This review aims to appraise the current literature identifying pathological factors associated with survival and tumour recurrence in patients undergoing exenterative surgery. A systematic review was carried out searching MEDLINE, EMBASE and COCHRANE Trials database for all studies assessing pathological factors influencing survival following pelvic exenteration for LARC or LRRC from 2010 to July 2021 following PRISMA guidelines. Risk of bias was assessed using QUIPS tool. Nine cohort studies met inclusion criteria, reporting outcomes for 2864 patients. Meta-analysis was not possible due to significant heterogeneity of reported outcomes. Resection margin status and nodal disease were the most commonly reported factors. A positive resection margin was demonstrated to be a negative prognostic marker in six studies. Involved lymph nodes and lymphovascular invasion also appear to be negative prognostic markers with tumour stage to be of lesser importance. No studies assessed other adverse tumour features that would not otherwise be included in a standard histopathology report. Pathological resection margin status is widely demonstrated to influence disease free and overall survival following pelvic exenteration for rectal cancer. With increasing R0 rates, other adverse tumour features must be explored to help elucidate differences in survival and potentially guide tailored oncological treatment.

28 April 2025 in Abdominal Radiology
Verified
Journal Article
Open access
PDF file
JRJason Rai
Jason Rai
DMDinh V. C. Mai
Dinh V. C. Mai
IDIoanna Drami
Ioanna Drami
EPEdward Pring
Edward Pring
LGLaura E. Gould
Laura E. Gould
JJJohn T Jenkins
John T Jenkins
Purpose: Predicting response to neoadjuvant therapy in locally advanced rectal cancer (LARC) is challenging. Organ preservation strategies can be offered to patients with complete clinical response. We aim to evaluate MRI-derived radiomics models in predicting complete pathological response (pCR). Methods: Search included MEDLINE, Embase and Cochrane Central Register of Controlled Trials (CENTRAL) and Cochrane Database of Systematic Reviews (CDSR) for studies published before 1st February 2024. The Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) and Radiomics Quality Score (RQS) tools were used to assess quality of included study. The research protocol was registered in PROSPERO (CRD42024512865). We calculated pooled area under the receiver operating characteristic curve (AUC) using a random-effects model. To compare AUC between subgroups the Hanley & McNeil test was performed. Results: Forty-four eligible studies (12,714 patients) were identified for inclusion in the systematic review. We selected thirty-five studies including 10,543 patients for meta-analysis. The pooled AUC for MRI radiomics predicted pCR in LARC was 0.87 (95% CI 0.84–0.89). In the subgroup analysis 3 T MRI field intensity had higher pooled AUC 0.9 (95% CI 0.87–0.94) than 1.5 T pooled AUC 0.82 (95% CI 0.80–0.83) p < 0.001. Asian ethnicity had higher pooled AUC 0.9 (95% CI 0.87–0.93) than non-Asian pooled AUC 0.8 (95% CI 0.75–0.84) p < 0.001. Conclusion: We have demonstrated that 3 T MRI field intensity provides a superior predictive performance. The role of ethnicity on radiomics features needs to be explored in future studies. Further research in the field of MRI radiomics is important as accurate prediction for pCR can lead to organ preservation strategy in LARC. Graphical

1 November 2022 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
IDIoanna Drami
Ioanna Drami
ALA.C. Lord
A.C. Lord
PSP. Sarmah
P. Sarmah
RBR.P. Baker
R.P. Baker
IDI.R. Daniels
I.R. Daniels
JJJ.T. Jenkins
J.T. Jenkins

28 February 2025 in Cancers
Verified
Journal Article
Open access
PDF file
DMDinh Van Chi Mai
Dinh Van Chi Mai
IDIoanna Drami
Ioanna Drami
EPEdward Tobias Pring
Edward Tobias Pring
LGLaura E. Gould
Laura E. Gould
JRJason Rai
Jason Rai
OGon behalf of the BiCyCLE Research Group
on behalf of the BiCyCLE Research Group
Background: A strong body of evidence exists demonstrating deleterious relationships between abnormal body composition (BC) and outcomes in non-complex colorectal cancer. Complex rectal cancer (RC) includes locally advanced and locally recurrent tumours. This scoping review aims to summarise the current evidence examining BC in complex RC. Methods: A literature search was performed on Ovid MEDLINE, EMBASE, and Cochrane databases. Original studies examining BC in adult patients with complex RC were included. Two authors undertook screening and full-text reviews. Results: Thirty-five studies were included. Muscle quantity was the most commonly studied BC metric, with sarcopenia appearing to predict mortality, recurrence, neoadjuvant therapy outcomes, and postoperative complications. In particular, 10 studies examined relationships between BC and neoadjuvant therapy response, with six showing a significant association with sarcopenia. Only one study examined interventions for improving BC in patients with complex RC, and only one study specifically examined patients undergoing pelvic exenteration. Marked variation was also observed in terms of how BC was quantified, both in terms of anatomical location and how cut-off values were defined. Conclusions: Sarcopenia appears to predict mortality and recurrence in complex RC. An opportunity exists for a meta-analysis examining poorer BC and neoadjuvant therapy outcomes. There is a paucity of studies examining interventions for poor BC. Further research examining BC specifically in patients undergoing pelvic exenteration surgery is also lacking. Pitfalls identified include variances in how BC is measured on computed tomography and whether external cut-off values for muscle and adipose tissue are appropriate for a particular study population.

15 September 2021 in Trials
Verified
Journal Article
Open access
PDF file
EPEdward Tobias Pring
Edward Tobias Pring
LGLaura E. Gould
Laura E. Gould
GMGeorge Malietzis
George Malietzis
PLPhilip Lung
Philip Lung
MBMina Bharal
Mina Bharal
OGon behalf of the BiCyCLE Research Group
on behalf of the BiCyCLE Research Group
Background: Colorectal cancer is associated with secondary sarcopenia (muscle loss) and myosteatosis (fatty infiltration of muscle) and patients who exhibit these host characteristics have poorer outcomes following surgery. Furthermore, patients, who undergo curative advanced rectal cancer surgery such as pelvic exenteration, are at risk of skeletal muscle loss due to immobility, malnutrition and a post-surgical catabolic state. Neuromuscular electrical stimulation (NMES) may be a feasible adjunctive treatment to help ameliorate these adverse side-effects. Hence, the purpose of this study is to investigate NMES as an adjunctive pre- and post-operative treatment for rectal cancer patients in the radical pelvic surgery setting and to provide early indicative evidence of efficacy in relation to key health outcomes.Method: In a phase II, double-blind, randomised controlled study, 58 patients will be recruited and randomised (1:1) to either a treatment (NMES plus standard care) or placebo (sham-NMES plus standard care) group. The intervention will begin 2 weeks pre-operatively and continue for 8 weeks after exenterative surgery. The primary outcome will be change in mean skeletal muscle attenuation, a surrogate marker of myosteatosis. Sarcopenia, quality of life, inflammatory status and cancer specific outcomes will also be assessed.Discussion: This phase II randomised controlled trial will provide important preliminary evidence of the potential for this adjunctive treatment. It will provide guidance on subsequent development of phase 3 studies on the clinical benefit of NMES for rectal cancer patients in the radical pelvic surgery setting.Trial registration: Protocol version 6.0; 05/06/20. ClinicalTrials.govNCT04065984. Registered on 22 August 2019; recruiting.

31 May 2025 in British Journal of Surgery
Verified
Journal Article
Closed access
JFJordan A Fletcher
Jordan A Fletcher
ACAlison Corr
Alison Corr
IDIoanna Drami
Ioanna Drami
CTClaire Taylor
Claire Taylor
THTherese Hona
Therese Hona
JJJohn T Jenkins
John T Jenkins
Background: Shared decision-making is essential for patient autonomy in complex rectal cancer requiring pelvic exenteration. Patients often lack understanding of procedures and risks, causing decisional conflict. Personalized three-dimensional (3D) models may improve patient education and decision-making. Methods: A single-centre mixed-methods randomized feasibility trial was conducted at St Mark’s Complex Cancer Clinic (June 2021–March 2022). Patients referred for pelvic exenteration were randomized 1 : 1 to standard consultation or standard consultation plus personalized 3D modelling. The primary qualitative objective explored patient engagement with 3D models through semi-structured interviews. The primary quantitative outcome assessed changes in decisional conflict scale (DCS) scores. Secondary outcomes included operative knowledge questionnaires and patient–surgeon agreement on functional outcomes. Results: Qualitative analysis showed that personalized 3D models enhanced patient understanding of complex anatomy, built trust, improved communication, and facilitated emotional processing. Quantitatively, a greater reduction occurred in DCS scores post-consultation in the 3D group (29 patients) compared with the standard group (22 patients) (median reduction of 36 versus 14 points; P = 0.005), though baseline scores differed. The 3D group demonstrated higher patient–surgeon agreement on functional outcomes (84% versus 60%; P < 0.001), despite greater operative complexity (median Pelvic Exenteration Lexicon score of 8 versus 4.5; P = 0.040). Conclusion: This feasibility study suggests that personalized 3D models may enhance comprehension and reduce decisional conflict in complex rectal cancer consultations. However, baseline differences between groups and lack of comparison with generic models limit definitive conclusions. Future research should address these methodological limitations and explore longer-term outcomes, such as decisional regret.